Feds investing $175 million in Vancouver company studying COVID-19
AbCellera Biologics studying antibodies that could be used to create a treatment
The federal government is investing millions to boost online access to health services and to support a Vancouver biological company's research into treatment and prevention of COVID-19.
Prime Minister Justin Trudeau announced the new funding during his daily news conference in Ottawa this morning as provinces across the country prepare to start re-opening on Monday.
The government is spending $240 million to boost access to online health services, including mental-health support and virtual access to doctors for primary care.
Ottawa is also providing $175 million to AbCellera Biologics Inc., which Trudeau says has shown promising signs of progress in identifying antibodies that could be used create a treatment for COVID-19.
In March, Ottawa announced that AbCellera was among several companies that will share $192 million under the federal government's new Strategic Innovation Fund's COVID-19 stream.
Answers on virus origins
Trudeau also says Canada will work with its allies to get answers around the spread of the novel coronavirus that causes COVID-19 following unsubstantiated reports the virus leaked from a Chinese lab.
But the prime minister insists the immediate focus is on helping Canadians through the pandemic.
- A previous version of this story said AbCellara is studying antibodies that could be used to create a treatment or vaccine for COVID-19. In fact, the company is working on treatment and prevention of the disease.May 03, 2020 3:45 PM PT